In addition, the frequency of circulating TEMs was found to be superior to levels of the HCC-specific serum marker AFP in differentiating HCC from chronic liver disease or cirrhosis and may, thus, also represent a complementary diagnostic biomarker for HCC [65]. This evidence concerns the gene AFP and hepatocellular carcinoma.